NCT06822036View on ClinicalTrials.gov

EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER

NARecruitingINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2027

Conditions
Prostate Cancer (Adenocarcinoma)Blood Loss, PostoperativeErectile Function
Interventions
PROCEDURE

Arm A - Application of 5g of ARISTA™ AH

Perioperative application of 5g of ARISTA™ AH to the prostate bed and neurovascular bundles during and at the end of the surgery to control bleeding and oozing in accordance with labelled directions; no other hemostyptic agent in aforementioned area

Trial Locations (3)

20246

NOT_YET_RECRUITING

Martini Klinik am UKE GmbH, Hamburg

48599

RECRUITING

St. Antonius-Hospital Gronau GmbH, Klinik für Urologie, Urologische Onkologie und Roboter-assistierte Chirurgie, Gronau

04103

NOT_YET_RECRUITING

Klinik und Poliklinik für Urologie des Universitätsklinikums Leipzig, Leipzig

Sponsors
All Listed Sponsors
collaborator

Becton, Dickinson and Company

INDUSTRY

collaborator

University of Leipzig

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

lead

St. Antonius Hospital Gronau

OTHER